NZ PHARMAC to fund boceprevir for hep C

August 2013, Volume 685, Issue 1, pp 11–11 | Cite as

News item

First Online: 24 August 2013

This is a preview of subscription content, to check access.

Reference

PHARMAC. Approval of decisions involving boceprevir and pegylated interferon with/without ribavirin. Internet Document : 9 Aug 2013. Available from: URL: http://www.pharmac.health.nz

Cite this article as:: PharmacoEcon Outcomes News (2013) 685: 11. https://doi.org/10.1007/s40274-013-0662-5

Get Access to

PharmacoEconomics & Outcomes News

for the whole of 2018